BRAIN Biotech AG (LON:0RFI)
2.300
0.00 (0.00%)
At close: Oct 23, 2025
BRAIN Biotech AG Revenue
BRAIN Biotech AG had revenue of 13.56M EUR in the quarter ending June 30, 2025, with 0.70% growth. This brings the company's revenue in the last twelve months to 53.61M, down -4.71% year-over-year. In the fiscal year ending September 30, 2024, BRAIN Biotech AG had annual revenue of 55.50M, down -1.29%.
Revenue (ttm)
53.61M EUR
Revenue Growth
-4.71%
P/S Ratio
0.91
Revenue / Employee
168.59K EUR
Employees
318
Market Cap
41.62M GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2024 | 55.50M | -726.00K | -1.29% |
| Sep 30, 2023 | 56.23M | 5.93M | 11.79% |
| Sep 30, 2022 | 50.30M | 11.07M | 28.23% |
| Sep 30, 2021 | 39.22M | 158.00K | 0.40% |
| Sep 30, 2020 | 39.06M | -982.00K | -2.45% |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shell | 198.54B |
| BP p.l.c. | 134.89B |
| Unilever | 51.24B |
| AstraZeneca | 41.24B |
| HSBC Holdings | 41.03B |
| Rio Tinto Group | 39.22B |
| GSK plc | 31.63B |
| British American Tobacco p.l.c. | 25.60B |